Tandem Diabetes Care Inc [TNDM] stock prices are up 5.98% to $16.84 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TNDM shares have gain 15.11% over the last week, with a monthly amount drifted -11.88%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on July 09, 2025, when Citigroup downgraded its rating to a Sell but kept the price target unchanged to $14 for it. Previously, Truist started tracking the stock with Hold rating on June 16, 2025, and set its price target to $24. On April 10, 2025, Mizuho initiated with a Neutral rating and assigned a price target of $20 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and decreased its price target to $22 on March 05, 2025. Citigroup downgraded its rating to a Neutral and reduced its price target to $24 on March 04, 2025. Wells Fargo downgraded its rating to Equal Weight for this stock on March 03, 2025, and downed its price target to $22. In a note dated February 28, 2025, Bernstein downgraded an Mkt Perform rating on this stock and revised its target price from $35 to $25.
The stock price of Tandem Diabetes Care Inc [TNDM] has been fluctuating between $14.31 and $47.60 over the past year. Currently, Wall Street analysts expect the stock to reach $33.33 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $16.84 at the most recent close of the market. An investor can expect a potential return of 97.92% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
The Tandem Diabetes Care Inc [NASDAQ:TNDM] reported sales of 982.95M for trailing twelve months, representing a surge of 22.30%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.16%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.83 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.19 points at the first support level, and at 15.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.20, and for the 2nd resistance point, it is at 17.56.
Ratios To Look Out For
It’s worth pointing out that Tandem Diabetes Care Inc [NASDAQ:TNDM]’s Current Ratio is 2.30. On the other hand, the Quick Ratio is 1.81, and the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 1.14, the price to book ratio is 7.22.
Transactions by insiders
Recent insider trading involved Kyrillos Jean-Claude, EVP & Chief Operating Officer, that happened on Mar 07 ’25 when 10538.0 shares were purchased. Director, BLICKENSTAFF KIM D completed a deal on Nov 21 ’24 to sell 30000.0 shares. Meanwhile, Director BLICKENSTAFF KIM D sold 10000.0 shares on Nov 20 ’24.
